Fourth, JapA specifically binds to MDM2 protein and has a better binding affinity than p53 peptide, and MDM2 expression is critical for JapA's anti-breast cancer activity as indicated in our assays using MDM2 overexpression and knockdown breast cancer cells. This evidence concerns the gene MDM2 and breast carcinoma.